Dual orexin receptor antagonist daridorexant for the treatment of adults with insomniaWANG Yong-yi, HUANG Lu, JIANG Cheng657-661
Lonapegsomatropin-tcgd, the first long-acting new drug for the treatment of childhood growth hormone deficiencyQIN Shuo, DU Xiao-li662-665
Considerations for the technical review of new drugs based on ICH Q11ZHAO Yi-fei, GUAN Meng-xin, WANG Ya-min666-669
Efficacy and safety comparison of ceftazidime avibactam versus colistin/polymyxin B in the treatment of carbapenem-resistant Gram-negative bacilli infection: a systematic reviewCAO Ye, YING Ying-qiu, LU Ming, ZHENG Jia-jia, YANG Li, ZHAI Suo-di670-675
Progress in the clinical study of antidepressant drugs with different mechanismsWANG Hui-ying, ZHOU Ai-nan, WU Jian-wei, XIE Peng, LI Jian-qi676-686
Current development status and prospects of Cichorium glandulosum:a medicinal and edible resource in XinjiangYANG Ming-han, LIANG Zheng-ting, LAN Wei695-702
Progress in research of chalcone-type natural product 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalconeLI Xu, SU Xiao-tong, WANG Wen-jun, MO Zhen-tao, XIAO Lu, LI Wen-na703-711
Tolerability and pharmacokinetics of sitafloxacin fumarate injection in Chinese volunteersLI Xiang-hong, XIN Yu-xia, SHAO Jing, SUN Hua, ZHOU Li-xiang, LIANG Da-hu, JIA Yuan-wei, SHEN Jie, XIE Hai-tang712-718
Interpretation of the"Core Patient-reported Outcomes in Cancer Clinical Trials Guidance for Industry ( draft)"LIU Ming-rui, YAO Mi, ZHOU Hui, GAO Xiang, YUAN Gang719-723